A Double-Blind, Placebo-Controlled Trial Assessing the Efficacy of Varenicline Tartrate for Alcohol Dependence
Open accessAbstract
OBJECTIVES: To assess the efficacy and safety of varenicline (Chantix) for the treatment of alcohol dependence. Varenicline is a partial α4β2 nicotinic acetylcholine agonist approved by the Food and Drug Administration for smoking cessation. It has reduced drinking in animal studies and in small studies of humans who were both heavy drinkers and smokers. This is the first multisite clinical trial of varenicline in a population of smokers and nonsmokers with alcohol dependence. METHODS: Men and women (n = 200) meeting the criteria for alcohol dependence were recruited across 5 clinical sites. Patients received double-blind varenicline or placebo and a computerized behavioral intervention. Varenicline was titrated during the first week to 2 mg/d, which was maintained during weeks 2 to 13. RESULTS: The varenicline group had significantly lower weekly percent heavy drinking days (primary outcome) (adjusted mean difference = 10.4), drinks per day, drinks per drinking day, and alcohol craving compared with the placebo group (P < 0.05). The average treatment effect on alcohol use was similar for smokers and nonsmokers. Varenicline was well-tolerated; adverse events were expected and mild. CONCLUSIONS: Varenicline significantly reduced alcohol consumption and craving, making it a potentially viable option for the treatment of alcohol dependence.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
There was no evidence of association between nicotinic receptor genes or pathways with DrnkWk.
“There was no evidence of association between nicotinic receptor genes or pathways with DrnkWk, despite the use of nicotinic receptor partial agonists (e.g., varenicline) in the treatment of alcohol dependence33.”
From Association studies of up to 1.2 million individuals yield new insights into the genetic etiology of tobacco and alcohol use (2019) · cites this paper as [33]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
(1998) · The Journal of Clinical Psychiatry · Cited by 19,139 · see citing works
Lim, S. S., Vos, T., Flaxman, A. D., Danaei, G., Shibuya, K., Adair-Rohani, H., AlMazroa, M. A., Amann, M., Anderson, H. R., Andrews, K. G., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61766-8 · Cited by 11,805 · see citing works
The Brief Psychiatric Rating Scale.
Overall, J. E., & Gorham, D. R. (1962) · Psychological Reports · doi:10.2466/pr0.1962.10.3.799 · Cited by 11,090 · see citing works
The Fagerstrom Test for Nicotine Dependence: a revision of the Fagerstrom Tolerance Questionnaire
HEATHERTON, T. F., KOZLOWSKI, L. T., FRECKER, R. C., & FAGERSTROM, K. (1991) · British Journal of Addiction · doi:10.1111/j.1360-0443.1991.tb01879.x · Cited by 10,738 · see citing works
(1998) · PubMed · Cited by 10,216 · see citing works
A simulation study of the number of events per variable in logistic regression analysis
Peduzzi, P., Concato, J., Kemper, E., Holford, T. R., & Feinstein, A. R. (1996) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(96)00236-3 · Cited by 9,655 · see citing works
Cohen, J. (1992) · Psychological Bulletin · doi:10.1037//0033-2909.112.1.155 · Cited by 8,771 · see citing works
The mini international neuropsychiatric interview
Lecrubier, Y., Sheehan, D. V., Hergueta, T., & Weiller, E. (1998) · European Psychiatry · doi:10.1016/s0924-9338(99)80239-9 · Cited by 5,882 · see citing works
Sobell, L. C., & Sobell, M. B. (1992) · Measuring Alcohol Consumption · doi:10.1007/978-1-4612-0357-5_3 · Cited by 4,110 · see citing works
Rehm, J., Mathers, C., Popova, S., Thavorncharoensap, M., Teerawattananon, Y., & Patra, J. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60746-7 · Cited by 3,870 · see citing works
Grant, B. F., Dawson, D. A., Stinson, F. S., Chou, S. P., Dufour, M. C., & Pickering, R. P. (2004) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2004.02.004 · Cited by 1,509 · see citing works
The relation between different dimensions of alcohol consumption and burden of disease: an overview
Rehm, J., Baliunas, D., Borges, G. L. G., Graham, K., Irving, H., Kehoe, T., Parry, C. D., Patra, J., Popova, S., Poznyak, V., et al. (2010) · Addiction · doi:10.1111/j.1360-0443.2010.02899.x · Cited by 1,174 · see citing works
Economic costs of excessive alcohol consumption in the U.S., 2006
Bouchery, E. E., Harwood, H. J., Sacks, J. J., Simon, C. J., & Brewer, R. D. (2011) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2011.06.045 · Cited by 1,041 · see citing works
Psychometric properties of the Penn Alcohol Craving Scale
Flannery, B. A., Volpicelli, J. R., & Pettinati, H. M. (1999) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.1999.tb04349.x · Cited by 852 · see citing works
Self-citationVarenicline Is a Partial Agonist at α4β2 and a Full Agonist at α7 Neuronal Nicotinic Receptors
Mihalak, K. B., Carroll, F. I., & Luetje, C. W. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.025130 · Cited by 558 · see citing works
Johnson, B. A. (2007) · JAMA · doi:10.1001/jama.298.14.1641 · Cited by 542 · see citing works
Self-citationMaisel, N. C., Blodgett, J. C., Wilbourne, P. L., Humphreys, K., & Finney, J. W. (2013) · Addiction · doi:10.1111/j.1360-0443.2012.04054.x · Cited by 470 · see citing works
GSK-3 and Wnt Signaling in Neurogenesis and Bipolar Disorder
Valvezan, A. J., & Klein, P. S. (2012) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2012.00001 · Cited by 384 · see citing works
Steensland, P., Simms, J. A., Holgate, J. Y., Richards, J. K., & Bartlett, S. E. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0705368104 · Cited by 368 · see citing works
Varenicline Reduces Alcohol Self-Administration in Heavy-Drinking Smokers
McKee, S. A., Harrison, E. L. R., O’Malley, S. S., Krishnan‐Sarin, S., Shi, J. M., Tetrault, J. M., Picciotto, M. R., Petrakis, I. L., Estevez, N., & Balchunas, E. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.01.029 · Cited by 302 · see citing works
Addiction and dependence in DSM‐V
O'Brien, C. (2011) · Addiction · doi:10.1111/j.1360-0443.2010.03144.x · Cited by 292 · see citing works
Form 90: A Structured Assessment Interview for Drinking and Related Behaviors: Test Manual
Miller, W. R. (1996) · PsycEXTRA Dataset · doi:10.1037/e563242012-001 · Cited by 248 · see citing works
Medications development to treat alcohol dependence: a vision for the next decade
Litten, R. Z., Egli, M., Heilig, M. A., Cui, C., Fertig, J. B., Ryan, M. L., Falk, D. E., Moss, H. B., Huebner, R. B., & Noronha, A. (2012) · Addiction Biology · doi:10.1111/j.1369-1600.2012.00454.x · Cited by 204 · see citing works
Self-citationInvolvement of Nicotinic Receptors in Alcohol Self-Administration
Lê, A. D., Corrigall, W., Watchus, J., Harding, S. E., Juzytsch, W., & Li, T. (2000) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2000.tb04585.x · Cited by 201 · see citing works
Tizabi, Y., Copeland, R., Louis, V. A., & Taylor, R. E. (2002) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2002.tb02551.x · Cited by 180 · see citing works
Varenicline decreases alcohol consumption in heavy-drinking smokers
Mitchell, J., Teague, C. H., Kayser, A. S., Bartlett, S. E., & Fields, H. L. (2012) · Psychopharmacology · doi:10.1007/s00213-012-2717-x · Cited by 179 · see citing works
Helping patients who drink too much: an evidence-based guide for primary care clinicians.
Willenbring, M. L., Massey, S. H., & Gardner, M. B. (2009) · PubMed · Cited by 159 · see citing works
Epidemiology and alcohol policy in Europe
Rehm, J. T., Zatonksi, W., Taylor, B., & Anderson, P. (2011) · Addiction · doi:10.1111/j.1360-0443.2010.03326.x · Cited by 147 · see citing works
Feduccia, A. A., Chatterjee, S., & Bartlett, S. E. (2012) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2012.00083 · Cited by 142 · see citing works
A preliminary investigation of varenicline for heavy drinking smokers
Fucito, L. M., Toll, B. A., Wu, R., Romano, D. M., Tek, E., & O’Malley, S. S. (2011) · Psychopharmacology · doi:10.1007/s00213-010-2160-9 · Cited by 124 · see citing works
Alcohol's actions on neuronal nicotinic acetylcholine receptors.
Davis, T. J., & de Fiebre, C. M. (2006) · PubMed · Cited by 115 · see citing works
Ericson, M., Löf, E., Stomberg, R., & Söderpalm, B. (2009) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.147058 · Cited by 109 · see citing works
Wouda, J. A., Riga, D., de Vries, W., Stegeman, M., van Mourik, Y., Schetters, D., Schoffelmeer, A. N. M., Pattij, T., & Vries, T. J. D. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2213-8 · Cited by 99 · see citing works
Grady, S. R., Drenan, R. M., Breining, S. R., Yohannes, D., Wageman, C. R., Fedorov, N. B., McKinney, S., Whiteaker, P., Bencherif, M., Lester, H. A., et al. (2010) · Neuropharmacology · doi:10.1016/j.neuropharm.2010.01.013 · Cited by 98 · see citing works
Acamprosate for Alcohol Dependence: A Sex‐Specific Meta‐Analysis Based on Individual Patient Data
Mason, B. J., & Lehert, P. (2011) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2011.01616.x · Cited by 95 · see citing works
The Genetic Components of Alcohol and Nicotine Co-Addiction: From Genes to Behavior
Schlaepfer, I. R., Hoft, N. R., & Ehringer, M. A. (2008) · Current Drug Abuse Reviews · doi:10.2174/1874473710801020124 · Cited by 93 · see citing works
Mecamylamine Modifies the Pharmacokinetics and Reinforcing Effects of Alcohol
Blomqvist, O., Hernández–Ávila, C. A., Kirk, J. V., Rose, J. E., & Kranzler, H. R. (2002) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2002.tb02541.x · Cited by 82 · see citing works
Positive and Negative Effects of Alcohol and Nicotine and Their Interactions: A Mechanistic Review
Hurley, L. L., Taylor, R. E., & Tizabi, Y. (2011) · Neurotoxicity Research · doi:10.1007/s12640-011-9275-6 · Cited by 79 · see citing works
Grucza, R. A., & Bierut, L. J. (2006) · PubMed Central · Cited by 77 · see citing works
Effect of transdermal nicotine replacement on alcohol responses and alcohol self-administration
McKee, S. A., O’Malley, S. S., Shi, J. M., Mase, T., & Krishnan‐Sarin, S. (2007) · Psychopharmacology · doi:10.1007/s00213-007-0952-3 · Cited by 73 · see citing works
Co-occurring risk factors for alcohol dependence and habitual smoking.
Bierut, L. J., Schuckit, M. A., HESSELBROCK, V. M., & Reich, T. (2000) · Europe PMC (PubMed Central) · Cited by 57 · see citing works
Lobeline and cytisine reduce voluntary ethanol drinking behavior in male C57BL/6J mice
Sajja, R. K., & Rahman, S. (2010) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.11.020 · Cited by 46 · see citing works
Ray, L. A., Miranda, R., Kahler, C. W., Leventhal, A. M., Monti, P. M., Swift, R. M., & Hutchison, K. E. (2007) · Psychopharmacology · doi:10.1007/s00213-007-0794-z · Cited by 43 · see citing works
Feinn, R., & Kranzler, H. R. (2005) · Alcoholism Clinical and Experimental Research · doi:10.1097/01.alc.0000171061.03686.bc · Cited by 32 · see citing works
Effects of Mecamylamine on Alcohol Consumption and Preference in Male C57BL/6J Mice
Farook, J. M., Lewis, B., Gaddis, J. G., Littleton, J. M., & Barron, S. (2009) · Pharmacology · doi:10.1159/000219488 · Cited by 31 · see citing works
Flagged first, then by citations
1 of the 47 references couldn’t be matched to a known paper.
Research works printed but not linked: 4
- Gonzales D Rennard S Nides M Varenicline, an α4β2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation JAMA 2006 296 1 47 55 16820546
- Johnson BA Rosenthal N Capece JA Topiramate for treating alcohol dependence: a randomized controlled trial JAMA 2007 298 1641 1651 17925516
- Lim SS Vos T Flaxman AD Danaei G Shibuya K Adair-Rohani H Amann M Anderson HR Lancet 2012 380 2224 2260 23245609 PMC4156511
- Szabo S The World Health Organization Quality of Life (WHOQOL) Spiker B Quality of Life and Pharmacoeconomics in Clinical Trials Philadelphia, PA Lippincott-Raven Publishers 1996 355 62
Cited by
Sorted by citations
23andMe Research Team, Liu, M., Psychiatry, H. A.-I., Jiang, Y., Wedow, R., Li, Y., Brazel, D. M., Chen, F., Datta, G., Davila-Velderrain, J., et al. (2019) · Nature Genetics · doi:10.1038/s41588-018-0307-5 · Cited by 1,896 · see citing works
Nicotine receptor partial agonists for smoking cessation
Cahill, K., Stead, L., & Lancaster, T. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006103.pub2 · Cited by 747 · see citing works
Advances in the science and treatment of alcohol use disorder
Witkiewitz, K. A., Litten, R. Z., & Leggio, L. (2019) · Science Advances · doi:10.1126/sciadv.aax4043 · Cited by 599 · see citing works
Self-citationSubstance Abuse Among Older Adults
Kuerbis, A., Sacco, P., Blazer, D. G., & Moore, A. A. (2014) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2014.04.008 · Cited by 505 · see citing works
Nicotine receptor partial agonists for smoking cessation
Cahill, K., Lindson-Hawley, N., Thomas, K. H., Fanshawe, T. R., & Lancaster, T. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006103.pub7 · Cited by 433 · see citing works
Connor, J. P., Haber, P. S., & Hall, W. D. (2016) · The Lancet · doi:10.1016/s0140-6736(15)00122-1 · Cited by 389 · see citing works
Kazdin, A. E. (2021) · Cambridge University Press eBooks · doi:10.1017/9781108993647.010 · Cited by 279 · see citing works
Alcohol Use in Patients with Chronic Liver Disease
Fuster, D., & Samet, J. H. (2018) · New England Journal of Medicine · doi:10.1056/nejmra1715733 · Cited by 207 · see citing works
Treatment of alcohol use disorders in patients with alcoholic liver disease
Addolorato, G., Mirijello, A., Barrio, P., & Gual, A. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.04.029 · Cited by 198 · see citing works
Novel Agents for the Pharmacological Treatment of Alcohol Use Disorder
Burnette, E. M., Nieto, S. J., Grodin, E. N., Meredith, L. R., Hurley, B., Miotto, K., Gillis, A. J., & Ray, L. A. (2022) · Drugs · doi:10.1007/s40265-021-01670-3 · Cited by 169 · see citing works
Cognitive control in alcohol use disorder: deficits and clinical relevance
Wilcox, C. E., Dekonenko, C. J., Mayer, A. R., Bogenschutz, M. P., & Turner, J. A. (2013) · Reviews in the Neurosciences · doi:10.1515/revneuro-2013-0054 · Cited by 162 · see citing works
An overview of alcohol and tobacco/nicotine interactions in the human laboratory
Verplaetse, T. L., & McKee, S. A. (2016) · The American Journal of Drug and Alcohol Abuse · doi:10.1080/00952990.2016.1189927 · Cited by 162 · see citing works
Thomas, K. H., Martin, R. M., Knipe, D. W., Higgins, J. P. T., & Gunnell, D. (2015) · BMJ · doi:10.1136/bmj.h1109 · Cited by 155 · see citing works
Thomas, K. H., Dalili, M. N., López-López, J. A., Keeney, E., Phillippo, D., Munafo, M. R., Stevenson, M., Caldwell, D. M., & Welton, N. J. (2021) · Health Technology Assessment · doi:10.3310/hta25590 · Cited by 153 · see citing works
State-of-the-art behavioral and pharmacological treatments for alcohol use disorder
Ray, L. A., Bujarski, S., Grodin, E. N., Hartwell, E. E., Green, R., Venegas, A., Lim, A. C., Gillis, A. J., & Miotto, K. A. (2018) · The American Journal of Drug and Alcohol Abuse · doi:10.1080/00952990.2018.1528265 · Cited by 136 · see citing works
Louvet, A., Labreuche, J., Moreno, C., Vanlemmens, C., Moirand, R., Féray, C., Dumortier, J., Pageaux, G.-P., Bureau, C., Chermak, F., et al. (2022) · The Lancet. Gastroenterology & hepatology · doi:10.1016/s2468-1253(21)00430-1 · Cited by 136 · see citing works
Falk, D. E., O’Malley, S. S., Witkiewitz, K., Anton, R. F., Litten, R. Z., Slater, M., Kranzler, H. R., Mann, K. F., Hasin, D. S., Johnson, B., et al. (2019) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2018.3079 · Cited by 120 · see citing works
Self-citationCarbone, M., Nardi, A., Flack, S., Carpino, G., Varvaropoulou, N., Gavrila, C., Spicer, A., Badrock, J., Bernuzzi, F., Cardinale, V., et al. (2018) · HAL · doi:10.1016/s2468-1253 · Cited by 119 · see citing works
Pharmacotherapy for alcohol dependence: status of current treatments
Franck, J., & Jayaram-Lindström, N. (2013) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2013.05.005 · Cited by 107 · see citing works
Varenicline for Treatment of Alcohol Dependence: A Randomized, Placebo‐Controlled Trial
de Bejczy, A., Löf, E., Walther, L., Guterstam, J., Hammarberg, A., Asanovska, G., Franck, J., Isaksson, A., & Söderpalm, B. (2015) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.12854 · Cited by 107 · see citing works
Nicotine receptor partial agonists for smoking cessation
Livingstone‐Banks, J., Fanshawe, T. R., Thomas, K. H., Theodoulou, A., Hajizadeh, A., Hartman, L., & Lindson, N. (2023) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006103.pub8 · Cited by 106 · see citing works
Medications for alcohol use disorders: An overview
Akbar, M. D., Egli, M., Cho, Y., Song, B., & Noronha, A. (2017) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.11.007 · Cited by 97 · see citing works
Reduced Drinking in Alcohol Dependence Treatment, What Is the Evidence?
Mann, K., Aubin, H.-J., & Witkiewitz, K. (2017) · European Addiction Research · doi:10.1159/000481348 · Cited by 93 · see citing works
Suchankova, P., Steensland, P., Fredriksson, I., Engel, J. A., & Jerlhag, E. (2013) · PLoS ONE · doi:10.1371/journal.pone.0071284 · Cited by 95 · see citing works
Developing neuroscience-based treatments for alcohol addiction: A matter of choice?
Heilig, M. A., Augier, E., Pfarr, S., & Sommer, W. H. (2019) · Translational Psychiatry · doi:10.1038/s41398-019-0591-6 · Cited by 95 · see citing works
Litten, R. Z., Wilford, B. B., Falk, D. E., Ryan, M. L., & Fertig, J. B. (2016) · Substance Abuse · doi:10.1080/08897077.2015.1133472 · Cited by 94 · see citing works
Self-citationPharmacotherapy for Alcohol Use Disorder
Swift, R. M., & Aston, E. R. (2015) · Harvard Review of Psychiatry · doi:10.1097/hrp.0000000000000079 · Cited by 92 · see citing works
O’Malley, S. S., Zweben, A., Fucito, L. M., Wu, R., Piepmeier, M. E., Ockert, D. M., Bold, K. W., Petrakis, I. L., Muvvala, S. B., Jatlow, P. I., et al. (2017) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2017.3544 · Cited by 94 · see citing works
Falk, D. E., Ryan, M. L., Fertig, J. B., Devine, E. G., Cruz, R., Brown, E. S., Burns, H., Salloum, I. M., Newport, D. J., Mendelson, J., et al. (2019) · Alcoholism: Clinical and Experimental Research · doi:10.1111/acer.13917 · Cited by 89 · see citing works
Self-citationSoyka, M., Kranzler, H. R., HESSELBROCK, V. M., Kasper, S. F., Mutschler, J., Möller, H., & The WFSBP Task Force on Treatment Guidelines for Substance Use Disorders (2016) · The World Journal of Biological Psychiatry · doi:10.1080/15622975.2016.1246752 · Cited by 86 · see citing works
Pharmacotherapy of alcoholism – an update on approved and off-label medications
Soyka, M., & Müller, C. A. (2017) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2017.1349098 · Cited by 89 · see citing works
Pharmacological approaches to reducing craving in patients with alcohol use disorders
Haass-Koffler, C. L., Leggio, L., & Kenna, G. A. (2014) · CNS Drugs · doi:10.1007/s40263-014-0149-3 · Cited by 83 · see citing works
Alcohol Use Disorder and Schizophrenia or Schizoaffective Disorder
Archibald, L. J. (2019) · Alcohol research · doi:10.35946/arcr.v40.1.06 · Cited by 85 · see citing works
Research Design in Clinical Psychology
Kazdin, A. E. (2021) · doi:10.1017/9781108993647 · Cited by 240 · see citing works
Orthosteric and allosteric potentiation of heteromeric neuronal nicotinic acetylcholine receptors
Wang, J., & Lindstrom, J. M. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13745 · Cited by 82 · see citing works
Ponizovsky, A. M., Rosca, P., Aronovich, E., Weizman, A., & Grinshpoon, A. (2014) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2014.11.007 · Cited by 80 · see citing works
for the National Institute on Alcohol Abuse and Alcoholism Clinical Investigations Group (NCIG) Study Group, Ryan, M. L., Falk, D. E., Fertig, J. B., Rendenbach-Mueller, B., Katz, D. A., Tracy, K. A., Strain, E. C., Dunn, K. E., Kampman, K., et al. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2016.214 · Cited by 72 · see citing works
Self-citationFeduccia, A. A., Simms, J. A., Mill, D., Yi, H. Y., & Bartlett, S. E. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12690 · Cited by 69 · see citing works
Nicotine receptor partial agonists for smoking cessation
Livingstone‐Banks, J., Fanshawe, T. R., Thomas, K. H., Theodoulou, A., Hajizadeh, A., Hartman, L., & Lindson, N. (2023) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006103.pub9 · Cited by 71 · see citing works
Litten, R. Z., Falk, D. E., Ryan, M. L., & Fertig, J. B. (2016) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.13093 · Cited by 70 · see citing works
Self-citationThe Glycine Receptor—A Functionally Important Primary Brain Target of Ethanol
Söderpalm, B., Lidö, H. H., & Ericson, M. (2017) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.13483 · Cited by 68 · see citing works
Feltmann, K., Borroto‐Escuela, D. O., Rüegg, J., Pinton, L., de Oliveira Sergio, T., Narváez, M., Jimenez‐Beristain, A., Ekström, T. J., Fuxe, K., & Steensland, P. (2018) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.13568 · Cited by 67 · see citing works
Current pharmacological treatment approaches for alcohol dependence
Müller, C. A., Geisel, O., Banas, R., & Heinz, A. (2014) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2014.876008 · Cited by 64 · see citing works
Tonstad, S., Arons, C., Rollema, H., Berlin, I., Hájek, P., Fagerström, K. O., Els, C., McRae, T. D., & Russ, C. (2020) · Current Medical Research and Opinion · doi:10.1080/03007995.2020.1729708 · Cited by 65 · see citing works
Varenicline in the Treatment of Alcohol Use Disorders
Erwin, B. L., & Slaton, R. M. (2014) · Annals of Pharmacotherapy · doi:10.1177/1060028014545806 · Cited by 62 · see citing works
Wilcox, C. E., Abbott, C., & Calhoun, V. D. (2018) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2018.06.011 · Cited by 61 · see citing works
Yardley, M. M., & Ray, L. A. (2016) · Addiction Biology · doi:10.1111/adb.12349 · Cited by 60 · see citing works
Witkiewitz, K., Falk, D. E., Kranzler, H. R., Litten, R. Z., Hallgren, K. A., O'Malley, S. S., Anton, R. F., & Workgroup, I. C. W. T. A. C. T. I. (. (2014) · Alcoholism: Clinical and Experimental Research · doi:10.1111/acer.12543 · Cited by 60 · see citing works
Self-citationAddiction, cognitive decline and therapy: Seeking ways to escape a vicious cycle
Perry, C. J., & Lawrence, A. J. (2017) · Genes, Brain and Behavior · doi:10.1111/gbb.12325 · Cited by 60 · see citing works
Schacht, J. P., Anton, R. F., Randall, P. K., Li, X., Henderson, S., & Myrick, H. (2014) · Psychopharmacology · doi:10.1007/s00213-014-3518-1 · Cited by 59 · see citing works
Tsai, P.-C., Bake, S., Balaraman, S., Rawlings, J. A., Holgate, R., DuBois, D. W., & Miranda, R. C. (2014) · Biology Open · doi:10.1242/bio.20147765 · Cited by 59 · see citing works
Falk, D. E., Castle, I. P., Ryan, M., Fertig, J. B., & Litten, R. Z. (2015) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000000133 · Cited by 59 · see citing works
Self-citationNicotinic receptor modulation to treat alcohol and drug dependence
Rahman, S., Engleman, E. A., & Bell, R. L. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2014.00426 · Cited by 58 · see citing works
Management of alcohol use disorder in patients with chronic liver disease
Mellinger, J. L., Fernandez, A. C., & Winder, G. S. (2023) · Hepatology Communications · doi:10.1097/hc9.0000000000000145 · Cited by 52 · see citing works
Substance use in older HIV-infected patients
Edelman, E. J., Tetrault, J. M., & Fiellin, D. A. (2014) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0000000000000069 · Cited by 49 · see citing works
Treatment-refractory substance use disorder: focus on alcohol, opioids, and cocaine
Soyka, M., & Mutschler, J. (2016) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2015.11.003 · Cited by 49 · see citing works
Alcohol use disorder in community management of chronic liver diseases
Leggio, L., & Mellinger, J. L. (2022) · Hepatology · doi:10.1002/hep.32531 · Cited by 50 · see citing works
Hurt, R. T., Ebbert, J. O., Croghan, I. T., Schroeder, D. R., Hurt, R. D., & Hays, J. T. (2018) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2017.11.017 · Cited by 48 · see citing works
Management of alcohol use disorder: a gastroenterology and hepatology-focused perspective
Díaz, L. A., König, D., Weber, S., Ayares, G., Fuentealba, J. M., Vázquez, V., Bataller, R. A., Kamath, P. S., Winder, G. S., Leggio, L., et al. (2025) · The Lancet. Gastroenterology & hepatology · doi:10.1016/s2468-1253(24)00380-7 · Cited by 50 · see citing works
Emerging pharmacotherapies for alcohol use disorder
Mason, B. J. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.04.032 · Cited by 46 · see citing works
Practical outpatient pharmacotherapy for alcohol use disorder
Kim, Y., Hack, L. M., Ahn, E. S., & Kim, J. (2018) · Drugs in Context · doi:10.7573/dic.212308 · Cited by 46 · see citing works
Leggio, L., Zywiak, W. H., Edwards, S. M., Tidey, J. W., Swift, R. M., & Kenna, G. A. (2014) · Psychopharmacology · doi:10.1007/s00213-014-3652-9 · Cited by 46 · see citing works
The Corticotropin Releasing Factor Receptor 1 in Alcohol Use Disorder: Still a Valid Drug Target?
Pomrenze, M. B., Fetterly, T. L., Winder, D. G., & Messing, R. O. (2017) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.13507 · Cited by 45 · see citing works
Morley, K. C., Perry, C. J., Watt, J., Hurzeler, T. P., Leggio, L., Lawrence, A. J., & Haber, P. (2021) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2021.1892641 · Cited by 44 · see citing works
Medications for treating alcohol use disorder: A narrative review
Kranzler, H. R., & Hartwell, E. E. (2023) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.15118 · Cited by 45 · see citing works
Overcoming the “Valley of Death” in Medications Development for Alcohol Use Disorder
Ray, L. A., Bujarski, S., Roche, D. J. O., & Magill, M. (2018) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.13829 · Cited by 42 · see citing works
Perez, E. E., Cardé, N. A. Q., & Biasi, M. D. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2015.80 · Cited by 41 · see citing works
Rohsenow, D. J., Tidey, J. W., Martin, R. A., Colby, S. M., Swift, R. M., Leggio, L., & Monti, P. M. (2017) · Addiction · doi:10.1111/add.13861 · Cited by 40 · see citing works
Critical needs in drug discovery for cessation of alcohol and nicotine polysubstance abuse
Skike, C. E. V., Maggio, S. E., Reynolds, A. R., Casey, E. M., Bardo, M. T., Dwoskin, L. P., Prendergast, M., & Nixon, K. (2015) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2015.11.004 · Cited by 39 · see citing works
Miranda, R., O’Malley, S. S., Padovano, H. T., Wu, R., Falk, D. E., Ryan, M. L., Fertig, J. B., Chun, T. H., Muvvala, S. B., & Litten, R. Z. (2020) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.14352 · Cited by 37 · see citing works
Self-citationRay, L. A., Green, R., Enders, C. K., Leventhal, A. M., Grodin, E. N., Li, G., Lim, A. C., Hartwell, E. E., Venegas, A., Meredith, L. R., et al. (2021) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2020.20070993 · Cited by 36 · see citing works
Roche, D. J. O., Ray, L. A., Yardley, M. M., & King, A. C. (2016) · Current Addiction Reports · doi:10.1007/s40429-016-0081-3 · Cited by 37 · see citing works
Funk, D. R., Lo, S. S. W., Coen, K. M., & Lê, A. D. (2015) · Behavioural Brain Research · doi:10.1016/j.bbr.2015.09.009 · Cited by 36 · see citing works
Fredriksson, I., Jayaram-Lindström, N., Wirf, M., Nylander, E., Nyström, E., Jardemark, K., & Steensland, P. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2014.294 · Cited by 35 · see citing works
Off-label and investigational drugs in the treatment of alcohol use disorder: A critical review
Fischler, P. V., Soyka, M., Seifritz, E., & Mutschler, J. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.927703 · Cited by 34 · see citing works
Pharmacotherapies and Personalized Medicine for Alcohol Use Disorder: A Review
Lohoff, F. W. (2020) · Pharmacogenomics · doi:10.2217/pgs-2020-0079 · Cited by 33 · see citing works
Blanco-Gandía, M. C., & Rodríguez‐Arias, M. (2018) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2018.08.007 · Cited by 33 · see citing works
Chichetto, N. E., Kundu, S., Freiberg, M. S., Butt, A. A., Crystal, S., So-Armah, K. A., Cook, R. L., Braithwaite, R. S., Fiellin, D. A., Khan, M. R., et al. (2019) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofz188 · Cited by 34 · see citing works
Medication Development for Alcohol Use Disorder: A Focus on Clinical Studies
Leggio, L., Falk, D. E., Ryan, M. L., Fertig, J. B., & Litten, R. Z. (2019) · Handbook of experimental pharmacology · doi:10.1007/164_2019_295 · Cited by 32 · see citing works
Self-citationVarenicline as a treatment for cannabis use disorder: A placebo-controlled pilot trial
McRae‐Clark, A. L., Gray, K. M., Baker, N. L., Sherman, B. J., Squeglia, L. M., Sahlem, G. L., Wagner, A. M., & Tomko, R. L. (2021) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2021.109111 · Cited by 30 · see citing works
Effects of Varenicline on Neural Correlates of Alcohol Salience in Heavy Drinkers
Vatsalya, V., Gowin, J. L., Schwandt, M. L., Momenan, R., Coe, M. A., Cooke, M. E., Hommer, D. W., Bartlett, S. E., Heilig, M. A., & Ramchandani, V. A. (2015) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyv068 · Cited by 30 · see citing works
Litten, R. Z., Falk, D. E., Ryan, M. L., Fertig, J. B., & Leggio, L. (2019) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.14233 · Cited by 30 · see citing works
Self-citationFeltmann, K., Fredriksson, I., Wirf, M., Schilström, B., & Steensland, P. (2015) · Addiction Biology · doi:10.1111/adb.12304 · Cited by 30 · see citing works
Witkiewitz, K. A., Anton, R. F., O’Malley, S. S., Hasin, D. S., Silverman, B. L., Aldridge, A., Mann, K. F., Kranzler, H. R., Aubin, H., Hoffman, M., et al. (2025) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2025.2508 · Cited by 29 · see citing works
Cippitelli, A., Schoch, J., Debevec, G., Brunori, G., Zaveri, N. T., & Toll, L. (2016) · Scientific Reports · doi:10.1038/srep26594 · Cited by 29 · see citing works
Dopamine and Alcohol Dependence: From Bench to Clinic
Jayaram‐Lindström, N., Ericson, M., Steensland, P., & Jerlhag, E. (2016) · InTech eBooks · doi:10.5772/63144 · Cited by 30 · see citing works
Anton, R. F., Latham, P. K., Voronin, K. E., Randall, P. K., Book, S. W., Hoffman, M., & Schacht, J. P. (2018) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.13601 · Cited by 29 · see citing works
Mobile alcohol biosensors and pharmacotherapy development research
Roberts, W., & McKee, S. A. (2018) · Alcohol · doi:10.1016/j.alcohol.2018.07.012 · Cited by 30 · see citing works
Advances in Pharmacotherapy Development: Human Clinical Studies
Litten, R. Z., Falk, D. E., Ryan, M. L., Fertig, J. B., & Leggio, L. (2017) · Handbook of experimental pharmacology · doi:10.1007/164_2017_79 · Cited by 29 · see citing works
Self-citationGhin, F., Beste, C., & Stock, A. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.12.031 · Cited by 29 · see citing works
Schoeler, T., Baldwin, J. R., Allegrini, A. G., Barkhuizen, W., McQuillin, A., Pirastu, N., Kutalik, Z., & Pingault, J. (2021) · Biological Psychiatry · doi:10.1016/j.biopsych.2022.07.027 · Cited by 25 · see citing works
Alcohol use disorder in alcohol-associated liver disease: Two sides of the same coin
Singal, A. K., Leggio, L., & DiMartini, A. F. (2023) · Liver Transplantation · doi:10.1097/lvt.0000000000000296 · Cited by 28 · see citing works
Management of Alcohol Use Disorder in Patients Requiring Liver Transplant
Lee, M. R., & Leggio, L. (2015) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2015.15040567 · Cited by 26 · see citing works
Field, M., Lemma, L. C. G. D., Christiansen, P., & Dickson, J. M. (2016) · Psychology of Addictive Behaviors · doi:10.1037/adb0000232 · Cited by 26 · see citing works
The role of varenicline on alcohol-primed self-administration and seeking behavior in rats
Randall, P. A., Jaramillo, A. A., Frisbee, S., & Besheer, J. (2015) · Psychopharmacology · doi:10.1007/s00213-015-3878-1 · Cited by 25 · see citing works
Lacroix, F., Pettorelli, A., Maddux, J.-M. N., Heidari-Jam, A., & Chaudhri, N. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2016.254 · Cited by 24 · see citing works
Gubner, N. R., McKinnon, C. S., & Phillips, T. J. (2014) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.12588 · Cited by 23 · see citing works
Effects of varenicline on alcohol cue reactivity in heavy drinkers
Roberts, W., Harrison, E. L. R., & McKee, S. A. (2017) · Psychopharmacology · doi:10.1007/s00213-017-4667-9 · Cited by 24 · see citing works
DeBaker, M. C., Moen, J. K., Robinson, J. M., Wickman, K. D., & Lee, A. M. (2019) · Psychopharmacology · doi:10.1007/s00213-019-05426-6 · Cited by 24 · see citing works
Pharmacotherapy of Co-Occurring Schizophrenia and Substance Use Disorders
Akerman, S. C., Brunette, M. F., Noordsy, D. L., & Green, A. I. (2014) · Current Addiction Reports · doi:10.1007/s40429-014-0034-7 · Cited by 23 · see citing works
Self-citation
- Authors
- Litten, R. Z., Ryan, M. L., Fertig, J. B., Falk, D. E., Johnson, B., Dunn, K. E., Green, A. I., Pettinati, H. M., Ciraulo, D. A., Sarid-Segal, O., Kampman, K., Brunette, M. F., Strain, E. C., Tiouririne, N. A., Ransom, J., Scott, C., & Stout, R.
- Affiliations
- Boston University (US)
- National Institutes of Health (US)
- University of Virginia (US)
- Dartmouth College (US)
- University of Pennsylvania (US)
- Johns Hopkins University (US)
- Fast Track Drugs and Biologics (US)
- Pacific Institute For Research and Evaluation (US)
- Corresponding author
- Litten, Raye Z.
- ORCID
- Venue
- Journal of Addiction Medicine
- Published
- 2013-07
- Volume
- 7
- Issue
- 4
- Pages
- 277-286
- ISSN
- 1932-0620 (ISSN-L)
- PMC
- PMC3914416
- OpenAlex
- W2006833508
- Cited by
- 287
- References
- 47
- Citations by year
- 2026: 7 · 2025: 15 · 2024: 10 · 2023: 25 · 2022: 9 · 2021: 40 · 2020: 21 · 2019: 24 · 2018: 25 · 2017: 26 · 2016: 26 · 2015: 25 · 2014: 26 · 2013: 7
- FWCI
- 20.40
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Addiction Medicine (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (4k24da023186-10)
- U.S. Public Health Service (HHSN27200900005C)
- National Institute on Alcohol Abuse and Alcoholism
- National Institute on Drug Abuse (K24-DA023186)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (HHSN275200900005C)
- Topics
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Health Sciences › Medicine › Pathology and Forensic Medicine › Alcohol Consumption and Health Effects
- Health Sciences › Medicine › Physiology › Smoking Behavior and Cessation
- Keywords
- varenicline, alcoholism, nicotinic agonists, alcohol craving, heavy drinking, smoking cessation, drug efficacy, drug safety
- MeSH terms
- Varenicline, Adult, Alcoholism, Benzazepines, Double-Blind Method, Female, Humans, Male, Middle Aged, Quinoxalines, Treatment Outcome, Medication Adherence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
